ArticleOncotarget2018
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.
Christian Posch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ArticleOncotarget2018
Christian Posch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.